544312 HAMPS

Hamps Bio Share Price

₹40.01 -1.79 (-4.28%)

25 Jun, 2025 07:39

SIP TrendupStart SIP in HAMPS

Start SIP

Performance

  • Low
  • ₹40
  • High
  • ₹40
  • 52 Week Low
  • ₹40
  • 52 Week High
  • ₹107
  • Open Price₹40
  • Previous Close₹42
  • Volume2,000

Investment Returns

  • Over 1 Month -11.7%
  • Over 3 Month -13.12%
  • Over 6 Month -60.57%
SIP Lightning

Smart Investing Starts Here Start SIP with Hamps Bio for Steady Growth!

Invest Now

Hamps Bio Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 58.5
  • PEG Ratio
  • -
  • Market Cap Cr
  • 17
  • P/B Ratio
  • 3
  • Average True Range
  • 1.57
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.25
  • RSI
  • 39.76
  • MFI
  • 37.82

Hamps Bio Financials

Hamps Bio Technicals

EMA & SMA

Current Price
₹40.01
-1.79 (-4.28%)
pointer
  • stock-down_img
  • Bearish Moving Average 11
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹42.66
  • 50 Day
  • ₹47.40
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

40.01 Pivot Speed
  • R3 40.01
  • R2 40.01
  • R1 40.01
  • S1 40.01
  • S2 40.01
  • S3 40.01

What's your outlook on Hamps Bio?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Hamps Bio Ltd. specializes in Pharmaceutical Formulation and Freeze-Dried Ingredients with two core divisions. Operating across Gujarat, Maharashtra, Rajasthan, and Madhya Pradesh, it serves B2B and B2C markets with therapeutic medicines and innovative freeze-dried food products.

Hamps Bio Ltd has an operating revenue of Rs. 16.29 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 6% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 10 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 13 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Hamps Bio Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-28 Audited Results

Hamps Bio F&O

Hamps Bio Shareholding Pattern

71.99%
0%
24.65%
3.36%

About Hamps Bio

  • NSE Symbol
  • HAMPS
  • BSE Symbol
  • 544312
  • Chairman & Managing Director
  • Mr. Herrik Shah
  • ISIN
  • INE0QBD01018

Similar Stocks to Hamps Bio

Hamps Bio FAQs

Hamps Bio share price is ₹40 As on 25 June, 2025 | 07:25

The Market Cap of Hamps Bio is ₹17.4 Cr As on 25 June, 2025 | 07:25

The P/E ratio of Hamps Bio is 58.5 As on 25 June, 2025 | 07:25

The PB ratio of Hamps Bio is 3 As on 25 June, 2025 | 07:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23